A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA
Aim. To compare the efficacy and safety of the slow-release isosorbide-5-mononitrate and of the nebivolol in patients with stable angina. Material and Methods. Patients (n=19) with ischemic heart disease (stable angina) were enrolled into randomized, double-blind, placebo-controlled, crossover study...
Saved in:
| Main Authors: | , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Столичная издательская компания
2016-01-01
|
| Series: | Рациональная фармакотерапия в кардиологии |
| Subjects: | |
| Online Access: | https://www.rpcardio.online/jour/article/view/897 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1849227817572630528 |
|---|---|
| author | S. Yu. Martsevich N. P. Kutishenko V. A. Egorov A. V. Zagrebel'nyy A. A. Serazhim Yu. V. Lukina N. A. Dmitrieva |
| author_facet | S. Yu. Martsevich N. P. Kutishenko V. A. Egorov A. V. Zagrebel'nyy A. A. Serazhim Yu. V. Lukina N. A. Dmitrieva |
| author_sort | S. Yu. Martsevich |
| collection | DOAJ |
| description | Aim. To compare the efficacy and safety of the slow-release isosorbide-5-mononitrate and of the nebivolol in patients with stable angina. Material and Methods. Patients (n=19) with ischemic heart disease (stable angina) were enrolled into randomized, double-blind, placebo-controlled, crossover study. They alternatively received nebivolol 5 mg QD or slow-release isosorbide-5-mononitrate 50 mg QD. The drug efficacy was assessed by changes in symptoms, angina attack number , sublingual nitroglycerin need, and treadmill test duration. Results. Patients treated with isosorbide-5-mononitrate shown significant increase in heart rate (HR) at rest in all time check-points in comparison with patients receiving placebo. HR significantly decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration of treadmill exercise significantly increased (vs placebo) 2 hours after a single intake of both isosorbide-5-mononitrate (454.3±37.1 vs 310.6±13.3 s; p <0.001) and nebivolol (428.6±33.3 vs 310.6±13.3 s; p<0.01). In one month of treatment isosorbide- 5-mononitrate and nebivolol reduced a number of angina episodes vs placebo (5.6±2.1 and 4.3±1.4, respectively , vs 8.6±2.4 episodes per month; p<0.05), the need for nitroglycerin (5.5±2.6 and 3.1±1.2, respectively , vs 6.7±2.2 sublingual tablets/month; p>0.05). No significant differences of these indicators were found between studied drugs. Conclusion. Nebivolol 5 mg daily is not inferior to slow-release isosorbide-5-mononitrate 50 mg daily in antianginal efficacy , significantly reduces HR, and much less causes headache and other side effects. |
| format | Article |
| id | doaj-art-bc20dcd4a80b43dc8ca73ac98d2de35e |
| institution | Kabale University |
| issn | 1819-6446 2225-3653 |
| language | English |
| publishDate | 2016-01-01 |
| publisher | Столичная издательская компания |
| record_format | Article |
| series | Рациональная фармакотерапия в кардиологии |
| spelling | doaj-art-bc20dcd4a80b43dc8ca73ac98d2de35e2025-08-23T10:00:23ZengСтоличная издательская компанияРациональная фармакотерапия в кардиологии1819-64462225-36532016-01-017555556010.20996/1819-6446-2011-7-5-41-45896A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINAS. Yu. Martsevich0N. P. Kutishenko1V. A. Egorov2A. V. Zagrebel'nyy3A. A. Serazhim4Yu. V. Lukina5N. A. Dmitrieva6State Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineState Research Center for Preventive MedicineCity polyclinic №93State Research Center for Preventive MedicineState Research Center for Preventive MedicineAim. To compare the efficacy and safety of the slow-release isosorbide-5-mononitrate and of the nebivolol in patients with stable angina. Material and Methods. Patients (n=19) with ischemic heart disease (stable angina) were enrolled into randomized, double-blind, placebo-controlled, crossover study. They alternatively received nebivolol 5 mg QD or slow-release isosorbide-5-mononitrate 50 mg QD. The drug efficacy was assessed by changes in symptoms, angina attack number , sublingual nitroglycerin need, and treadmill test duration. Results. Patients treated with isosorbide-5-mononitrate shown significant increase in heart rate (HR) at rest in all time check-points in comparison with patients receiving placebo. HR significantly decreased 2 hours after nebivolol intake both single one and after 30 days of treatment (p<0.001). Duration of treadmill exercise significantly increased (vs placebo) 2 hours after a single intake of both isosorbide-5-mononitrate (454.3±37.1 vs 310.6±13.3 s; p <0.001) and nebivolol (428.6±33.3 vs 310.6±13.3 s; p<0.01). In one month of treatment isosorbide- 5-mononitrate and nebivolol reduced a number of angina episodes vs placebo (5.6±2.1 and 4.3±1.4, respectively , vs 8.6±2.4 episodes per month; p<0.05), the need for nitroglycerin (5.5±2.6 and 3.1±1.2, respectively , vs 6.7±2.2 sublingual tablets/month; p>0.05). No significant differences of these indicators were found between studied drugs. Conclusion. Nebivolol 5 mg daily is not inferior to slow-release isosorbide-5-mononitrate 50 mg daily in antianginal efficacy , significantly reduces HR, and much less causes headache and other side effects.https://www.rpcardio.online/jour/article/view/897beta-blockerisosorbide-5-mononitrateantianginal efficacyischemic heart diseaseexercise tolerance testside effects |
| spellingShingle | S. Yu. Martsevich N. P. Kutishenko V. A. Egorov A. V. Zagrebel'nyy A. A. Serazhim Yu. V. Lukina N. A. Dmitrieva A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA Рациональная фармакотерапия в кардиологии beta-blocker isosorbide-5-mononitrate antianginal efficacy ischemic heart disease exercise tolerance test side effects |
| title | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA |
| title_full | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA |
| title_fullStr | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA |
| title_full_unstemmed | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA |
| title_short | A COMPARATIVE STUDY OF EFFICACY AND TOLERABILITY OF ANTIANGINAL DRUGS OF DIFFERENT GROUPS — NITROVASODILATATOR (ISOSORBIDE-5-MONONITRATE SUSTAINED RELEASE) AND BETA-BLOCKER WITH VASODILATING ACTION (NEBIVOLOL) — IN PATIENTS WITH STABLE ANGINA |
| title_sort | comparative study of efficacy and tolerability of antianginal drugs of different groups nitrovasodilatator isosorbide 5 mononitrate sustained release and beta blocker with vasodilating action nebivolol in patients with stable angina |
| topic | beta-blocker isosorbide-5-mononitrate antianginal efficacy ischemic heart disease exercise tolerance test side effects |
| url | https://www.rpcardio.online/jour/article/view/897 |
| work_keys_str_mv | AT syumartsevich acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT npkutishenko acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT vaegorov acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT avzagrebelnyy acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT aaserazhim acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT yuvlukina acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT nadmitrieva acomparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT syumartsevich comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT npkutishenko comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT vaegorov comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT avzagrebelnyy comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT aaserazhim comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT yuvlukina comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina AT nadmitrieva comparativestudyofefficacyandtolerabilityofantianginaldrugsofdifferentgroupsnitrovasodilatatorisosorbide5mononitratesustainedreleaseandbetablockerwithvasodilatingactionnebivololinpatientswithstableangina |